Atrium Therapeutics

RNA

Capitalización de mercado USD 131 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
51	51 ADAR1 Capital Management Austin, Texas	USD 776 k	–	–	–
52	52 Franklin Resources San Mateo, California	USD 763 k	+USD 741 k	+56,699	Nuevas
53	53 Jacobs Levy Equity Management Florham Park, New Jersey	USD 726 k	+USD 705 k	+53,992	Nuevas
54	54 ODDO BHF Asset Management Paris, France	USD 606 k	–	–	–
55	55 Caxton Associates (UK) London,	USD 595 k	–	–	–
56	ACM 56 Alethea Capital Management Mercer Island, Washington	USD 589 k	–	–	–
57	57 Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada	USD 564 k	–	–	–
58	58 Morgan Stanley New York	USD 564 k	-USD 1.61 M	-123,094	-75%
59	59 Saba Capital Management New York	USD 533 k	–	–	–
60	60 Bank of New York Mellon New York	USD 528 k	-USD 58.1 k	-4,445	-10%
61	61 Y-Intercept (HK) Hong Kong	USD 472 k	+USD 459 k	+35,103	Nuevas
62	62 Kennedy Capital Management St Louis, Missouri	USD 470 k	+USD 13.1 k	+1,002	+3%
63	63 Fidelity Investments Boston, Massachusetts	USD 451 k	+USD 55.4 k	+4,240	+14%
64	64 Moran Wealth Management Naples, Florida	USD 448 k	+USD 435 k	+33,320	Nuevas
65	65 Boussard & Gavaudan Gestion SAS Paris, France	USD 447 k	+USD 429 k	+32,845	Nuevas
66	66 LMR Partners London, United Kingdom	USD 437 k	–	–	–
67	67 Los Angeles Capital Management Los Angeles, California	USD 423 k	+USD 411 k	+31,477	Nuevas
68	68 Nuveen Charlotte, North Carolina	USD 418 k	+USD 75.3 k	+5,764	+23%
69	69 Jump Financial Chicago, Illinois	USD 417 k	+USD 405 k	+31,017	Nuevas
70	70 Quantinno Capital Management New York	USD 369 k	+USD 195 k	+14,964	+120%
71	TS 71 Twin Securities New York	USD 357 k	-USD 306 k	-23,396	-47%
72	OL 72 Odyssean LLC Darien, Connecticut	USD 286 k	+USD 277 k	+21,233	Nuevas
73	73 Brevan Howard Capital Management St. Helier, Jersey	USD 280 k	-USD 141 k	-10,810	-34%
74	74 Fractal Investments Glastonbury, Connecticut	USD 269 k	–	–	–
75	75 UBS Group Zurich, Switzerland	USD 263 k	-USD 395 k	-30,242	-61%

Atrium Therapeutics RNA Capitalización de mercado USD 131 M

Atrium Therapeutics

RNA

Capitalización de mercado USD 131 M